Ƶ

Vaccine Skepticism Spreads to Pets; Generics for ADHD Approved; Malaria in Maryland

— Health news and commentary from around the Web gathered by Ƶ staff

Ƶ MedicalToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require registration or subscription.

Some like rabies, survey data showed. (Vaccine)

The FDA approved multiple (ADHD) in children 6 years and older and adults, as well as binge-eating disorder in adults.

The Biden administration announced the first 10 drugs up for Medicare price negotiations.

Some individuals said semaglutide (Ozempic,Wegovy) (NPR)

In northern Mexico, an epidemic of Rocky Mountain spotted fever, a tick-borne disease, and hundreds of deaths in recent years. (Washington Post)

China will drop its from international travelers starting Wednesday. (The Hill)

A case of locally-acquired malaria in Maryland from previous cases in Florida and Texas, the CDC said.

Michigan Gov. Gretchen Whitmer (D) will call on state lawmakers . (Associated Press)

Pfizer announced plans to at the North Carolina factory damaged by a tornado in July. (Fierce Pharma)

Astronauts on NASA's SpaceX Crew-7 mission began conducting biomedical research on the International Space Station as part of medical research effort. (Fierce Biotech)

Europe will continue to have a through September, the European Medicines Agency said. (Reuters)

A saved the life of a child; could widespread use could help millions more? (AP)

Monday after a brief hospital stay following a fall. (People)

The FDA (Reblozyl) to treat anemia in adults with low- to intermediate-risk myelodysplastic syndromes who might require regular blood transfusions, Bristol Myers Squibb said.

Samuel "Joe" Wurzelbacher, during the 2008 presidential campaign, died Sunday at age 49 from pancreatic cancer. (The Hill)

  • author['full_name']

    Michael DePeau-Wilson is a reporter on Ƶ’s enterprise & investigative team. He covers psychiatry, long covid, and infectious diseases, among other relevant U.S. clinical news.